Yabing Du
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Probiotics and Fermented Foods
Papers in
-
- Cancer-related molecular mechanisms research 3
-
- Immune cells in cancer 4
- Co-authors
- Kang Cui (12 shared papers)Wang Ma (13 shared papers)Ke‐Neng Chen (2 shared papers)Luyan Shen (2 shared papers)Yurong Du (4 shared papers)Huan Zhao (5 shared papers)Shuiling Jin (2 shared papers)Junlin Yu (1 shared paper)
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Genetics (2 papers)Hepatology Communications (1 paper)Oncotarget (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Yabing Du
21 papers receiving 327 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 54
- Food Science 20
- Oncology 24
- Otorhinolaryngology 6
- Biotechnology 4
Countries citing papers authored by Yabing Du
This map shows the geographic impact of Yabing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Du more than expected).
Fields of papers citing papers by Yabing Du
This network shows the impact of papers produced by Yabing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Du. The network helps show where Yabing Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yabing Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 42 | |
| 2 | 2014 | 35 | |
| 3 | 2019 | 35 | |
| 4 | 2021 | 32 | |
| 5 | 2019 | 26 | |
| 6 | 2022 | 25 | |
| 7 | 2017 | 20 | |
| 8 | 2024 | 18 | |
| 9 | 2023 | 16 | |
| 10 | 2023 | 16 | |
| 11 | 2020 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2020 | 2 |
About Yabing Du
Yabing Du is a scholar working on Cancer Research, Immunology, Biotechnology, Surgery and Health, Toxicology and Mutagenesis, having authored 24 papers that have together received 332 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (2 papers), Esophageal Cancer Research and Treatment (2 papers), Inflammatory Bowel Disease (1 paper), Cancer Research and Treatments (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Cancer Research (54 citations), Food Science (20 citations), Oncology (24 citations), Otorhinolaryngology (6 citations) and Biotechnology (4 citations). Yabing Du has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Kang Cui, Wang Ma, Ke‐Neng Chen, Luyan Shen, Yurong Du, Huan Zhao, Shuiling Jin, Junlin Yu, Hao Tang and Qingxia Fan. Their work appears in journals such as Frontiers in Oncology, Frontiers in Genetics, Hepatology Communications, Oncotarget and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.